Shandong Weigao Group Medical Polymer Co (HKSE:01066) Interest Expense : HK$-299 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shandong Weigao Group Medical Polymer Co's interest expense for the six months ended in Dec. 2023 was HK$ -147 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-299 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shandong Weigao Group Medical Polymer Co's Operating Income for the six months ended in Dec. 2023 was HK$ 992 Mil. Shandong Weigao Group Medical Polymer Co's Interest Expense for the six months ended in Dec. 2023 was HK$ -147 Mil. Shandong Weigao Group Medical Polymer Co's Interest Coverage for the quarter that ended in Dec. 2023 was 6.73. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Weigao Group Medical Polymer Co Interest Expense Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Interest Expense Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-442.82

-212.12

-171.97

-213.74

-298.57

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-87.85	-83.90	-133.81	-151.13	-147.44

Shandong Weigao Group Medical Polymer Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-299 Mil.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Weigao Group Medical Polymer Co's Interest Expense for the six months ended in Dec. 2023 was HK$-147 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$992 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$1,746 Mil.

Shandong Weigao Group Medical Polymer Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	992.133	/	-147.438
	=	6.73

The higher the ratio, the stronger the company's financial strength is.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Executives

Wei Hai Wei Gao Guo Ji Yi Liao Tou Zi Kong Gu You Xian Gong Si
Wei Gao Ji Tuan You Xian Gong Si
Chen Xueli	2201 Interest of corporation controlled by you

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines